PHS
INNV icon

PFM Health Sciences’s InnovAge Holding INNV Stock Holding History

PFM Health Sciences’s Portfolio INNV Stock Details INNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-429,699
Closed -$9.16M – 94
2021
Q2 		$9.16M Hold
429,699
– – 0.29% 66
2021
Q1 		$11.1M Buy
+429,699
New +$10.6M 0.34% 61

Other funds holding INNV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PFM Health Sciences's INNV Position: Q3 2021 in Review

PFM Health Sciences sold out of InnovAge Holding (INNV) in Q3 2021, closing a stake of 429,699 shares — an estimated $9.16M sold.

PFM Health Sciences first reported a position in INNV in Q1 2021 and held it in 2 quarters. The position peaked at $11.1M in Q1 2021. 67 funds tracked by Wall St. Rank hold INNV as of Q3 2021.

  • PFM Health Sciences reported no remaining InnovAge Holding position as of Q3 2021 after selling out during the quarter.
  • PFM Health Sciences sold 429,699 InnovAge Holding shares in Q3 2021, an estimated $9.16M.
  • PFM Health Sciences first reported a position in InnovAge Holding in Q1 2021 and held it in 2 quarters.
  • PFM Health Sciences's InnovAge Holding position peaked at $11.1M in Q1 2021.
  • 67 funds tracked by Wall St. Rank held InnovAge Holding as of Q3 2021.

Based on PFM Health Sciences's 13F filing for Q3 2021, filed 15 Nov 2021.